How are MMSI strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MMSI strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 35.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,160.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a MMSI strangle?

The breakeven for the MMSI strangle priced on this page is roughly $48.40 and $76.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MMSI market-implied 1-standard-deviation expected move is approximately 10.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current MMSI implied volatility affect this strangle?

MMSI ATM IV is at 35.40% with IV rank near 5.03%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

MMSI Strangle Strategy

MMSI (Merit Medical Systems, Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally.

MMSI (Merit Medical Systems, Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $3.74B, a trailing P/E of 26.74, a beta of 0.58 versus the broader market, a 52-week range of 59.74-100.05, average daily share volume of 817K, a public-listing history dating back to 1990, approximately 7K full-time employees. These structural characteristics shape how MMSI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.58 indicates MMSI has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a strangle on MMSI?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current MMSI snapshot

As of May 15, 2026, spot at $61.30, ATM IV 35.40%, IV rank 5.03%, expected move 10.15%. The strangle on MMSI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 217-day expiry.

Why this strangle structure on MMSI specifically: MMSI IV at 35.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a MMSI strangle, with a market-implied 1-standard-deviation move of approximately 10.15% (roughly $6.22 on the underlying). The 217-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MMSI expiries trade a higher absolute premium for lower per-day decay. Position sizing on MMSI should anchor to the underlying notional of $61.30 per share and to the trader's directional view on MMSI stock.

MMSI strangle setup

The MMSI strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MMSI near $61.30, the first option leg uses a $65.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MMSI chain at a 217-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MMSI shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$65.00	$6.05
Buy 1	Put	$60.00	$5.55

MMSI strangle risk and reward

Net Premium / Debit: -$1,160.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$1,160.00
Breakeven(s): $48.40, $76.60
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

MMSI strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on MMSI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$4,839.00
$13.56	-77.9%	+$3,483.73
$27.12	-55.8%	+$2,128.47
$40.67	-33.7%	+$773.20
$54.22	-11.5%	-$582.07
$67.77	+10.6%	-$882.67
$81.33	+32.7%	+$472.60
$94.88	+54.8%	+$1,827.86
$108.43	+76.9%	+$3,183.13
$121.98	+99.0%	+$4,538.40

When traders use strangle on MMSI

Strangles on MMSI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MMSI chain.

MMSI thesis for this strangle

The market-implied 1-standard-deviation range for MMSI extends from approximately $55.08 on the downside to $67.52 on the upside. A MMSI long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current MMSI IV rank near 5.03% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MMSI at 35.40%. As a Healthcare name, MMSI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MMSI-specific events.

MMSI strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MMSI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MMSI alongside the broader basket even when MMSI-specific fundamentals are unchanged. Always rebuild the position from current MMSI chain quotes before placing a trade.

Frequently asked questions

What is a strangle on MMSI?: A strangle on MMSI is the strangle strategy applied to MMSI (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MMSI stock trading near $61.30, the strikes shown on this page are snapped to the nearest listed MMSI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are MMSI strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MMSI strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 35.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,160.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MMSI strangle?: The breakeven for the MMSI strangle priced on this page is roughly $48.40 and $76.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MMSI market-implied 1-standard-deviation expected move is approximately 10.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on MMSI?: Strangles on MMSI are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MMSI chain.
How does current MMSI implied volatility affect this strangle?: MMSI ATM IV is at 35.40% with IV rank near 5.03%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.